🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kyoung‐Mee Kim

Samsung Medical Center

ORCID: 0000-0002-1162-9205

Also affiliated with Sungkyunkwan University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Determinants of Response to Sequential Pembrolizumab with Trastuzumab plus Platinum/5-FU in HER2-Positive Gastric Cancer: A Phase II Chemoimmunotherapy Trial”.

Determinants of Response to Sequential Pembrolizumab with Trastuzumab plus Platinum/5-FU in HER2-Positive Gastric Cancer: A Phase II Chemoimmunotherapy Trial

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3528

N/A

0.370DataRank · unranked

8 citations

Minae An, Hyuk Lee, You Jeong Heo, Byung‐Hoon Min, Arnav Mehta +6 more

Improved survival of gastric cancer with tumour Epstein–Barr virus positivity: an international pooled analysis

UNC Libraries(2020)10.17615/vppm-0n77

N/A

0DataRank · unranked

1 citations

Anna Maria Chiaravalli, Keitaro Matsuo, Yuko Kijima, Carlos Alberto Zúniga González, Linda M. Liao +19 more

Phase 2 of extracellular RNA communication consortium charts next-generation approaches for extracellular RNA research

iScience(2022)10.1016/j.isci.2022.104653

N/A

0DataRank · unranked

31 citations

Jennifer Jones, Roger P. Alexander, Eric Alsop, Ji Yeong An, Mohammad H. Asghari +91 more

Distinct Spatially Resolved Tumor Microenvironment Trajectories Define Benefit from Ramucirumab plus Pembrolizumab in Refractory PD-L1+ Gastric Cancer

Cancer Immunology Research(2025)10.1158/2326-6066.cir-25-0625

N/A

0DataRank · unranked

6 citations

Minae An, You Jeong Heo, Hyuk Lee, Byung‐Hoon Min, Arnav Mehta +6 more